Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways

por Meng, Xiangqi, Zhao, Yu, Han, Bo, Zha, Caijun, Zhang, Yangong, Li, Ziwei, Wu, Pengfei, Qi, Tengfei, Jiang, Chuanlu, Liu, Yang, Cai, Jinquan
Publicado 2020

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma

por Han, Bo, Meng, Xiangqi, Wu, Pengfei, Li, Ziwei, Li, Siyi, Zhang, Yangong, Zha, Caijun, Ye, Qile, Jiang, Chuanlu, Cai, Jinquan, Jiang, Tao
Publicado 2020

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer

por Li, Lulu, Wu, Pengfei, Wang, Zhenyu, Meng, Xiangqi, Zha, Caijun, Li, Ziwei, Qi, Tengfei, Zhang, Yangong, Han, Bo, Li, Shupeng, Jiang, Chuanlu, Zhao, Zheng, Cai, Jinquan
Publicado 2020

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

por Chen, Yunping, Mu, Yu, Guan, Qing, Li, Chenlong, Zhang, Yangong, Xu, Yinzhi, Zhou, Chong, Guo, Ying, Ma, Yanan, Zhao, Meiqi, Ji, Guohua, Liu, Peng, Sun, Donglin, Sun, Haiming, Wu, Nan, Jin, Yan
Publicado 2023